| Lastest Insider Transactions Of Ultragenyx Pharmaceutical Inc. ( RARE ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| RARE | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Directior | 2026-06-15 | Sell | 2,000 | 25.05 | 50,100 | 2026-06-15 18:50:54 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2026-06-15 | Sell | 1,899 | 24.62 | 46,753 | 2026-06-15 18:46:33 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2026-06-01 | Sell | 4,653 | 23.77 | 110,602 | 2026-06-01 19:11:52 |
| RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Directior | 2026-05-14 | Sell | 5,740 | 25.12 | 144,189 | 2026-05-18 18:41:18 |
| RARE | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | 2026-05-05 | Sell | 344 | 24.96 | 8,586 | 2026-05-06 14:51:11 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2026-05-01 | Sell | 4,683 | 24.90 | 116,607 | 2026-05-04 17:35:58 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2026-04-01 | Sell | 4,683 | 20.97 | 98,203 | 2026-04-02 18:19:58 |
| RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | 2026-03-01 | Sell | 10,029 | 22.80 | 228,661 | 2026-03-03 19:09:43 |
| RARE | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | 2026-03-01 | Sell | 10,539 | 22.80 | 240,289 | 2026-03-03 19:08:17 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2026-03-01 | Sell | 54,404 | 22.80 | 1,240,411 | 2026-03-03 19:06:19 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2026-03-01 | Sell | 8,135 | 22.80 | 185,478 | 2026-03-03 18:51:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2026-03-02 | Sell | 1,632 | 22.80 | 37,210 | 2026-03-03 18:51:08 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2026-03-01 | Sell | 10,044 | 22.65 | 227,538 | 2026-03-03 18:50:25 |
| RARE | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | 2026-03-01 | Sell | 7,029 | 22.80 | 160,261 | 2026-03-03 18:49:45 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2026-02-02 | Sell | 3,061 | 23.56 | 72,117 | 2026-02-03 12:00:41 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2026-01-02 | Sell | 3,150 | 22.84 | 71,946 | 2026-01-05 16:07:21 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2025-12-29 | Sell | 85 | 34.38 | 2,922 | 2025-12-30 13:49:27 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2025-12-10 | Sell | 3,081 | 36.38 | 112,087 | 2025-12-11 12:10:22 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2025-10-13 | Sell | 7,942 | 31.51 | 250,252 | 2025-10-14 12:15:06 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2025-09-18 | Sell | 64 | 29.17 | 1,867 | 2025-09-19 18:23:43 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2025-09-12 | Sell | 2,450 | 31.17 | 76,367 | 2025-09-12 16:11:58 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2025-09-05 | Sell | 84 | 31.39 | 2,637 | 2025-09-08 14:01:44 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2025-09-05 | Sell | 84 | 31.39 | 2,637 | 2025-09-08 14:01:44 |
| RARE | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Directior | 2025-06-20 | Sell | 2,405 | 37.39 | 89,923 | 2025-06-23 13:50:13 |
| RARE | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | 2025-04-21 | Sell | 762 | 37.93 | 28,901 | 2025-05-05 19:18:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2025-03-06 | Sell | 1,785 | 40.40 | 72,114 | 2025-03-10 12:53:00 |
| RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | 2025-03-01 | Sell | 6,028 | 42.10 | 253,779 | 2025-03-04 20:19:57 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2025-03-01 | Sell | 12,846 | 42.10 | 540,817 | 2025-03-04 20:18:24 |
| RARE | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | 2025-03-01 | Sell | 8,945 | 42.10 | 376,585 | 2025-03-04 20:16:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | 2025-03-01 | Sell | 14,439 | 42.10 | 607,882 | 2025-03-04 20:12:26 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2025-02-28 | Sell | 98,434 | 42.20 | 4,153,572 | 2025-03-04 20:10:16 |
| RARE | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | 2025-03-01 | Sell | 15,103 | 42.10 | 635,836 | 2025-03-04 20:06:23 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2025-03-01 | Sell | 967 | 42.10 | 40,711 | 2025-03-04 20:00:32 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2025-02-27 | Sell | 2,990 | 42.88 | 128,224 | 2025-03-03 13:58:32 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2025-02-27 | Sell | 2,990 | 42.88 | 128,224 | 2025-03-03 13:58:32 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2024-12-30 | Sell | 11,727 | 42.23 | 495,231 | 2024-12-31 14:05:40 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2024-12-09 | Sell | 8,273 | 50.00 | 413,650 | 2024-12-11 18:44:06 |
| RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Chief Financial Officer | 2024-10-10 | Sell | 7,465 | 52.76 | 393,853 | 2024-10-11 16:48:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2024-08-06 | Sell | 20,000 | 50.17 | 1,003,400 | 2024-08-07 14:48:02 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2024-08-06 | Sell | 20,000 | 50.17 | 1,003,400 | 2024-08-07 14:48:02 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2024-08-06 | Sell | 20,000 | 50.17 | 1,003,400 | 2024-08-07 14:48:02 |
| RARE | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Directior | 2024-07-02 | Sell | 584 | 40.98 | 23,932 | 2024-07-03 14:07:33 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2024-06-12 | Sell | 9,806 | 45.00 | 441,270 | 2024-06-12 19:47:14 |
| RARE | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Directior | 2024-06-10 | Sell | 1,737 | 41.10 | 71,391 | 2024-06-10 19:58:22 |
| RARE | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | 2024-05-02 | Sell | 354 | 43.66 | 15,456 | 2024-05-03 15:23:35 |
| RARE | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | 2024-04-18 | Sell | 142 | 44.10 | 6,262 | 2024-04-19 16:35:51 |
| RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | 2024-03-11 | Sell | 11,509 | 49.93 | 574,644 | 2024-03-12 13:41:05 |
| RARE | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Directior | 2024-03-07 | Sell | 12,195 | 50.88 | 620,443 | 2024-03-11 12:54:59 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2024-03-01 | Sell | 3,756 | 53.76 | 201,923 | 2024-03-05 20:22:18 |
| RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | 2024-03-01 | Sell | 1,011 | 53.76 | 54,351 | 2024-03-05 20:19:45 |
| RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | 2024-03-01 | Sell | 4,173 | 53.76 | 224,340 | 2024-03-05 20:15:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2024-03-01 | Sell | 341 | 53.76 | 18,332 | 2024-03-05 20:13:18 |
| RARE | Ultragenyx Pharmaceutical Inc. | Crombez Eric | EVP and Chief Medical Officer | 2024-03-01 | Sell | 1,238 | 53.76 | 66,555 | 2024-03-05 20:10:42 |
| RARE | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | 2024-03-01 | Sell | 4,768 | 53.76 | 256,328 | 2024-03-05 20:08:18 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2024-02-07 | Sell | 30,000 | 45.00 | 1,350,000 | 2024-02-08 15:49:34 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2023-12-29 | Sell | 30,000 | 47.87 | 1,436,100 | 2024-01-02 16:07:46 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2023-12-20 | Option Exercise | 3,000 | 21.00 | 63,000 | 2024-01-02 16:06:43 |
| RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | 2023-10-23 | Sell | 39,878 | 32.78 | 1,307,201 | 2023-10-24 17:22:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | 2023-10-23 | Option Exercise | 39,878 | 6.86 | 273,563 | 2023-10-24 17:22:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2023-10-19 | Sell | 47,853 | 33.52 | 1,604,033 | 2023-10-23 17:14:33 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2023-10-19 | Option Exercise | 47,853 | 6.86 | 328,272 | 2023-10-23 17:14:33 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2023-09-07 | Sell | 2,163 | 40.80 | 88,249 | 2023-09-11 13:52:12 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2023-09-07 | Option Exercise | 2,000 | 21.00 | 42,000 | 2023-09-11 13:52:12 |
| RARE | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | 2023-09-05 | Sell | 6,000 | 37.96 | 227,760 | 2023-09-06 17:51:47 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2023-09-01 | Sell | 970 | 37.15 | 36,032 | 2023-09-06 17:50:58 |
| RARE | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Directior | 2023-06-30 | Sell | 585 | 46.76 | 27,355 | 2023-06-30 14:34:29 |
| RARE | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | 2023-06-19 | Sell | 305 | 48.20 | 14,701 | 2023-06-21 18:17:06 |
| RARE | Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. | Directior | 2023-06-07 | Sell | 1,485 | 51.65 | 76,700 | 2023-06-09 14:31:34 |
| RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | 2023-05-18 | Sell | 2,012 | 50.00 | 100,600 | 2023-05-19 13:54:14 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2023-05-09 | Option Exercise | 3,000 | 21.00 | 63,000 | 2023-05-10 20:09:31 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2023-05-04 | Sell | 4,378 | 45.00 | 197,010 | 2023-05-05 14:16:23 |
| RARE | Ultragenyx Pharmaceutical Inc. | Bedrosian Camille L | EVP and Chief Medical Officer | 2023-03-01 | Sell | 3,881 | 45.25 | 175,615 | 2023-03-03 20:00:36 |
| RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP and Chief Legal Officer | 2023-03-01 | Sell | 3,161 | 45.25 | 143,035 | 2023-03-03 19:59:40 |
| RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | CBO & EVP | 2023-03-01 | Sell | 1,968 | 45.27 | 89,091 | 2023-03-03 19:57:33 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2023-03-01 | Sell | 100 | 45.65 | 4,565 | 2023-03-03 19:54:57 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | 2023-03-01 | Sell | 389 | 45.65 | 17,758 | 2023-03-03 19:53:55 |
| RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | 2023-03-01 | Sell | 3,755 | 45.26 | 169,951 | 2023-03-03 19:53:02 |
| RARE | Ultragenyx Pharmaceutical Inc. | Harris Erik | EVP & Chief Commercial Officer | 2023-03-01 | Sell | 3,664 | 45.25 | 165,796 | 2023-03-03 19:51:21 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2023-02-28 | Sell | 639 | 43.40 | 27,733 | 2023-03-02 14:28:00 |
| RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | President & CEO | 2022-12-30 | Sell | 19,582 | 45.57 | 892,352 | 2023-01-03 16:45:10 |
| RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 2022-12-21 | Sell | 2,031 | 43.96 | 89,283 | 2022-12-22 13:24:42 |
